Table IV. Univariate and multivariate survival analyses for prognostic significance of programmed death ligand-1 (PD-L1) SP142 expression on immune cells (ICs) and clinicopathologic parameters of 132 patients with triple-negative breast cancer.

CI: Confidence interval; HR: hazard ratio; NA: not applicable. *Statistically significant.